| NCT Number | NCT07224906 |
| Lead Sponsor | HemoCept Inc. |
| Conditions | Pulmonary Hypertension, Congestive Heart Failure(CHF), Valve Disease, Heart |
| Enrollment | 50 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2027-01 (estimated) |
| Study Completion | 2027-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-13 |